ReviewJournal of hepatocellular carcinoma2023

Evidence to Date: Clinical Utility of Tremelimumab in the Treatment of Unresectable Hepatocellular Carcinoma.

Zunirah Ahmed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.